{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:02:04Z","timestamp":1768460524345,"version":"3.49.0"},"reference-count":17,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T00:00:00Z","timestamp":1319760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Since anthracyclines were introduced in the treatment of non-Hodgkin\u2019s lymphoma in the late 1960s, they have been acknowledged as a cornerstone in the management of the disease and, in particular, of aggressive lymphomas. The high efficacy of anthracycline-containing regimens must, however, be balanced against the drug-related toxicity, which mainly affects the cardiovascular system and represents a major concern for clinicians, especially in the treatment of elderly patients. Patients\u2019 outcomes could be further improved, particularly for those at high risk of cardiotoxicity, by substituting liposomal doxorubicin for conventional doxorubicin. This approach has already been tested and shown to be effective in several cancers, especially in different subsets of patients with diffuse large B-cell lymphoma. The use of liposomal doxorubicin in combination regimens for other conditions, such as follicular lymphoma and splenic marginal zone lymphoma, is also under investigation, and early results are promising.<\/jats:p>","DOI":"10.4081\/hr.2011.s3.e4","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T14:42:43Z","timestamp":1320763363000},"page":"e4","source":"Crossref","is-referenced-by-count":16,"title":["Anthracyclines: A Cornerstone in the Management of Non-Hodgkin\u2019s Lymphoma"],"prefix":"10.3390","volume":"3","author":[{"given":"Stefano","family":"Luminari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Montanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2011,10,28]]},"reference":[{"key":"ref1","first-page":"945","article-title":"Fertility in Thalassemia: The Greek Experience","volume":"11","author":"Karagiorga-Lagana","year":"1998","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0609.1997.tb00729.x","article-title":"Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia","volume":"59","author":"Jensen","year":"1997","journal-title":"Eur J Haematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1749-6632.1990.tb24317.x","article-title":"Endocrine abnormalities in Thalassemia","volume":"612","author":"Vullo","year":"1990","journal-title":"Ann Ny Acad Sci"},{"key":"ref4","first-page":"133","article-title":"Endocrine problems in Beta-Thalassemia major","volume":"6","author":"Jensen","year":"1994","journal-title":"Contemp Rev Obstet Gynaecol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00008480-199608000-00019","article-title":"Reproduction health in patients with Beta-Thalassemia","volume":"8","author":"Tolis","year":"1996","journal-title":"Curr Opin Pediatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/adc.55.7.572","article-title":"Successful pregnancy in transfusion dependent Thalassemia","volume":"55","author":"Thomas","year":"1980","journal-title":"Arch Dis Child"},{"key":"ref7","first-page":"182","article-title":"Successful pregnancy in beta Thalassemia major","volume":"19","author":"Martin","year":"1983","journal-title":"Aus Paediatr J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1479-828X.1984.tb03320.x","article-title":"A successful pregnancy outcome in transfusion dependent Thalassaemia major","volume":"24","author":"Meadows","year":"1884","journal-title":"Aus NZ J Obstet Gynaecol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00006254-199402000-00025","article-title":"Beta-Thalassemia syndromes and pregnancy","volume":"49","author":"Savona-Ventura","year":"1994","journal-title":"Obstet Gynecol Surv"},{"key":"ref10","first-page":"294","article-title":"Beta-Thalassemia major and successful pregnancy","volume":"42","author":"Kumar","year":"1997","journal-title":"J Reprod Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0301-2115(97)00089-4","article-title":"Transfusion-dependent homozygous beta-Thalassaemia major: successful pregnancy in five cases","volume":"74","author":"Tampakoudis","year":"1997","journal-title":"Eur J Obstet Reprod Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-0528.1998.tb10270.x","article-title":"Pregnancy and homozygous beta thalassaemia major","volume":"105","author":"Daskalakis","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"ref13","first-page":"923","article-title":"Pregnancy management and outcomes in women with Thalassemia major","volume":"11","author":"Tuck","year":"1998","journal-title":"J Paediatr Endocrinol Metab"},{"key":"ref14","first-page":"183","article-title":"Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases","volume":"78","author":"Vaskaridou","year":"1993","journal-title":"Haematologica"},{"key":"ref15","first-page":"1045","article-title":"Induzione della ovulazione in paziente beta talassemica omozigote","volume":"6","author":"Negri","year":"1991","journal-title":"Medicina e Morale"},{"key":"ref16","first-page":"935","article-title":"Fertility in Female Patients with Thalassemia","volume":"11","author":"Skordis","year":"1998","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental blood transplants from unrelated donors","volume":"339","author":"Rubinstein","year":"1998","journal-title":"New Engl J Med"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/3\/13\/e4\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T06:41:05Z","timestamp":1645598465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/3\/13\/e4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,28]]},"references-count":17,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2011,12]]}},"alternative-id":["hr.2011.s3.e4"],"URL":"https:\/\/doi.org\/10.4081\/hr.2011.s3.e4","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,28]]}}}